<DOC>
	<DOCNO>NCT00793702</DOCNO>
	<brief_summary>The primary objective ass safety three dose level ( 0.01 , 0.1 1.0 µg ) rdESAT-6 + rCFP-10 skin test reagent inject healthy adult . The secondary objective ass risk sensitisation 0.01 0.1 µg rdESAT-6 + rCFP-10 inject twice time interval 6 12 week healthy adult .</brief_summary>
	<brief_title>Safety Risk Sensitisation rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>1 . Has sign inform consent 2 . Is willing likely able comply trial procedure 3 . Is female/male nonblack adult ≥ 18 year ≤ 55 year age 4 . Is healthy accord medical examination , medical history laboratory investigation inclusion 5 . Is prepared grant authorize person access medical record 1 . Has history tuberculosis know contact person active tuberculosis 2 . Has positive QuantiFERONTB Gold In Tube test result inclusion 3 . Laboratory parameter outside normal range judge principal investigator clinically significant and/or abnormal glucose protein level urine sample inclusion 4 . Has treatment product likely modify immune response within 3 month prior day inclusion ( e.g. , immunoglobulin , systemic corticosteroid , methotrexate , azathioprine , cyclosporine , infliximab blood product ) 5 . Has vaccinate live vaccine within 6 month prior day inclusion ( e.g. , MMR , yellow fever , oral typhoid vaccine ) 6 . Has know congenital acquire immune deficiency 7 . Has disease affect lymphoid organ ( e.g. , Hodgkin 's disease , lymphoma , leukemia , sarcoidosis ) 8 . Is know infected HIV , HBV HCV 9 . Has severe ongoing viral bacterial infection might affect cell mediate immune response inclusion 10 . Has Creactive protein ( CRP ) level &gt; 50 mg/L 11 . Has severe scarring , burn , rash , eczema , psoriasis , skin disease near injection site ( ) 12 . Has condition repeat blood drawing pose minimal risk volunteer , haemophilia , coagulation disorder , significantly impaired venous access 13 . Is actively participate another clinical trial participate previous clinical trial investigate rdESAT6 skin test reagent 14 . Is pregnant accord urine pregnancy test inclusion 15 . Is female willing use contraceptive breastfeed 16 . Has condition opinion investigator suitable participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>tuberculosis</keyword>
	<keyword>diagnosis</keyword>
	<keyword>ESAT-6</keyword>
	<keyword>CFP-10</keyword>
	<keyword>skin test</keyword>
	<keyword>Skin test diagnosis tuberculosis infection</keyword>
</DOC>